nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-D8661632·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Clinical medicine·Subfield: Physiology·Basis: Full text·Type: Laboratory experiment

Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson's disease.

Sheshadri et al.Sheshadri, Costa-Besada, Fisher et al.·2026·Translational neurodegeneration·10.1186/s40035-026-00559-z ↗

Primary claim

the disruption of V-ATPase assembly driven by MTORC1 activation impairs lysosomal acidification. This causes impairment of mitophagy, leading to mitochondrial dysfunction

Tentative · the causal chain relies on one MTORC1 inhibitor and a pH-sensitive mitophagy reporter
In brief

Patient-derived models link GBA1 mutations to lysosomal and mitochondrial dysfunction, but a pH-sensitive mitophagy reporter weakens the proposed causal rescue mechanism.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that it works through the path described. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

BACKGROUND: Heterozygous mutations in the glucocerebrosidase gene (GBA1), which encodes the lysosomal enzyme β-glucocerebrosidase (GCase), are a genetic risk factor for Parkinson's disease (PD). The pathophysiological consequences of GBA1 mutations on dopaminergic neuronal function, especially their impact on lysosomal function, mitophagy, and mitochondrial bioenergetics, remain unclear.

METHODS: Fibroblasts and dopaminergic neurons generated from induced pluripotent stem cells (iPSCs) derived from patients with GBA1-PD were used in the study. Live-cell imaging was performed to measure lysosomal acidification, protease activity, mitochondrial membrane potential, and mitophagy. Mitochondrial morphology and autophagic vesicles were examined using transmission electron microscopy. Oxygen consumption rate was measured by Seahorse assay. V-ATPase assembly was quantified using fluorescence lifetime imaging with Förster resonance energy transfer (FLIM-FRET), and pharmacological interventions included rapamycin and acidic nanoparticles.

RESULTS: GCase activity, lysosomal acidification, protease activity, mitophagy and mitochondrial bioenergetic function were all impaired in GBA1 mutant dopaminergic neurons. Mitochondria were fragmented, with reduced membrane potential and oxygen consumption. Mechanistic target of rapamycin complex 1 (MTORC1) was constitutively phosphorylated and FLIM-FRET measurements confirmed impairment of lysosomal V-ATPase assembly, which was reversed by rapamycin treatment. Rapamycin and lysosome-targeting acidic nanoparticles rescued lysosomal pH and restored mitophagy, mitochondrial membrane potential and mitochondrial oxidative phosphorylation complex level in the GBA1 mutant dopaminergic neurons.

CONCLUSIONS: We revealed a novel mechanistic link between GBA1 mutations and mitochondrial dysfunction, as the disruption of V-ATPase assembly driven by MTORC1 activation impairs lysosomal acidification. This causes impairment of mitophagy, leading to mitochondrial dysfunction, undermining dopaminergic cell function and fate. Pharmacological intervention with rapamycin or acidic nanoparticles restores lysosomal pH and rescue mitochondrial function, representing a novel therapeutic approach for GBA1-PD .

Key Claims

Primary finding · Tentative

the disruption of V-ATPase assembly driven by MTORC1 activation impairs lysosomal acidification. This causes impairment of mitophagy, leading to mitochondrial dysfunction

Fragile — the claim's weakest requirement is that it works through the path described. Based on how the study was designed and conducted, not on statistics extracted from the paper. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

the causal chain relies on one MTORC1 inhibitor and a pH-sensitive mitophagy reporter

Abstract, Conclusions
Quote verified
Secondary · Supported

GCase activity, lysosomal acidification, protease activity, mitophagy and mitochondrial bioenergetic function were all impaired in GBA1 mutant dopaminergic neurons.

isogenic comparisons support the phenotype, although the mitophagy measure is sensitive to lysosomal acidity

Abstract; Results, Figs. 1–3
Quote verified
Secondary · Tentative

Rapamycin and lysosome-targeting acidic nanoparticles rescued lysosomal pH and restored mitophagy, mitochondrial membrane potential and mitochondrial oxidative phosphorylation complex level in the GBA1 mutant dopaminergic neurons.

pH-sensitive mt-Keima and complex-specific protein changes do not establish broad functional rescue

Abstract; Results, Fig. 5 and Fig. S4i
Quote verified
Secondary · Supported

FLIM-FRET measurements confirmed impairment of lysosomal V-ATPase assembly, which was reversed by rapamycin treatment.

fibroblast FLIM-FRET and fractionation support impaired assembly, but rapamycin reversal is partial and not neuronally replicated by FLIM

Abstract; Results, Fig. 4
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#methodological rigour

Isogenic patient-cell comparisons across variants

E326K and N370S patient-derived neurons are compared with CRISPR-corrected isogenic controls across lysosomal, mitochondrial, and mitophagy-associated endpoints.

↳ Results, opening paragraph; Figs. 1–5; Table S1

#contribution

Convergent lysosomal and mitochondrial phenotyping

Lysosensor, DQRed BSA, TMRM, TEM, Seahorse respirometry, lysosomal fractionation, and FLIM-FRET address distinct parts of the proposed cellular pathway.

↳ Methods; Results, Figs. 1–4

#positioning

Competing mechanisms receive substantive discussion

The discussion compares the findings with direct mitochondrial GBA1 and mitochondria–lysosome contact models and identifies unresolved MTORC1 activation as a remaining gap.

↳ Discussion, paragraphs on TBC1D15, complex I, and MTORC1

Limitations

#methodological rigour

Mitophagy rescue is not independently identified

Because mt-Keima reports mitochondrial exposure to acidic environments, lowering lysosomal pH can increase its signal without demonstrating increased mitophagic delivery or flux.

↳ Methods, Measurement of Mitophagy Using mt-Keima Reporter; Results, Fig. 5c

#reporting

Causal and functional language overreaches

The conclusions state that lysosomal pH restoration rescues mitophagy and therefore mitochondrial function, although respiration was not re-measured after treatment and cell fate was not assessed.

↳ Abstract; Conclusions; Results, Fig. 5 and Fig. S4i

#methodological rigour

Intervention statistics and reporting conflict

Fig. 5 uses uncorrected Fisher’s LSD despite the methods stating that adjusted P-values are reported for multiple comparisons; complex I direction also conflicts between baseline and rescue text.

↳ Methods, Quantification and Statistical Analysis; Fig. 5 legend; Results, Fig. 2e and Fig. S4i

Does this match your read? Add your assessment ↓

Nabu Commentary

The contribution score reflects the integration of two GBA1 variants, isogenic neuronal controls, and multiple lysosomal and mitochondrial assays. Methodological Rigour is constrained by the central use of a pH-sensitive mt-Keima signal to infer restored mitophagic flux after experimentally lowering lysosomal pH, compounded by ambiguity about experimental units. Reporting and context are reduced because the abstract and conclusions present the pH-to-mitophagy-to-mitochondria sequence as established without carrying this assay limitation into the interpretation. The translational direction is credible but remains at an early cell-model stage.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.0±0.2

Contribution
3.7

The study meaningfully connects lysosomal pH, V-ATPase assembly, mitophagy-associated signals, and mitochondrial phenotypes in two GBA1 variants with isogenic controls. The mechanistic advance is real but constrained by cell models and incomplete identification of the proposed causal chain.

Results, Figs. 1–5; Discussion, competing mechanistic models

“The FLIM-FRET data thus confirmed impaired assembly of the V-ATPase complex in GBA1 mutant cells.”

Methodological Rigour
2.7

The design combines isogenic controls, multiple cellular readouts, blinded TEM, and two pH-directed interventions. However, mt-Keima directly responds to acidity, so its treatment response cannot independently establish restored mitophagic flux, and the experimental unit remains incompletely specified.

Methods, Measurement of Mitophagy Using mt-Keima Reporter; Methods, Quantification and Statistical Analysis; Fig. 5

“The high F543:F458 ratio values were generated… and used as an index of mitophagy.”

Reporting
3.0

The results progress coherently from lysosomal and mitochondrial phenotypes to mechanism and intervention. The abstract and conclusions nevertheless describe a causal cascade and mitochondrial-function rescue more strongly than warranted because respiratory rescue and pH-independent mitophagic flux were not measured.

Abstract, Conclusions; Results, Fig. 5 and Fig. S4i

“restoring lysosomal pH is sufficient to rescue lysosomal function and mitophagy”

Positioning
2.8

The discussion engages alternative GBA1 mechanisms, adjacent neurodegenerative literature, allele-specific OXPHOS variation, and rapamycin’s broad effects. It does not trace the pH sensitivity of mt-Keima into the certainty of its central pH-to-mitophagy inference.

Discussion, paragraphs on competing mechanisms, rapamycin, and acidic nanoparticles

“Since rapamycin has broad effects, the comparison to NPs is valuable”

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Rapamycin and lysosome-targeting acidic nanoparticles rescued lysosomal pH and restored mitophagy, mitochondrial membrane potential and mitochondrial oxidative phosphorylation complex level in the GBA1 mutant dopaminergic neurons: "increased expression of complex I proteins in N370S DA" (Results, Mitochondria are dysfunctional in cells with GBA1-PD mutations, Fig. 2e) vs "the reduced complex I level in the N370S DA neurons were normalised upon treatment with either rapamycin or acidic NPs." (Results, Acidification of lysosomes is sufficient to restore lysosomal and mitochondrial functions as well as mitophagy, Fig. S4i). The baseline Results describe increased N370S complex I expression, whereas the rescue paragraph describes normalisation of a reduced baseline level. → Not supported by the paper's own data
Reporting and transparencyNoted

Reporting gaps concern the adjustment policy for rescue comparisons, the definition of sample size and statistical tests, the absence of an explicit ethics approval declaration, and the lysosomal protein-loading unit.

Ethics approval: not stated · Data availability: declared

Reference IntegrityClean

79 references in manuscript 79 of 79 checkable references found in an index

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Neurological · Parkinson's disease
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesMedium
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The mechanism and rescue were demonstrated only in controlled in vitro patient-derived fibroblast and iPSC-neuron cultures with no animal or human testing.

From the paper
“We highlight that lysosomal pH correction is a pivotal, unifying therapeutic target in GBA1-PD.”

The paper names a therapeutic use of its findings but does not identify who would specifically act on them or in what setting.

Pathway

Drug developers and clinical researchers could test lysosomal pH-correcting agents like rapamycin or acidic nanoparticles as disease-modifying therapies for GBA1-PD patients.

Barrier

All evidence is from in vitro cell culture; demonstrating safety and efficacy in animal models and human clinical trials remains entirely untested.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Defective Lysosomal Lipolysis Causes Prenatal Lipid Accumulation and Exacerbates Immediately after Birth

    Kuentzel, Bradić, Akhmetshina, et al. · 2021 · Basic medicine

    Primary claim

    defective lysosomal but not neutral lipolysis alters placental and fetal cholesterol homeostasis and exhibits an initial disease pathology already in utero as Lal-/- fetuses accumulate hepatic lysosomal lipids.

    Tentative
    Evidence Score
    3.4±0.2
    Reliability
    No concerns
  2. Vascular Function and Cardiorespiratory Fitness in Adults Who Use Nicotine Vapes

    Maxime Boidin, Hans Degens, Rehan T. Junejo, et al. · 2026 · Health sciences

    Primary claim

    Regular daily nicotine vape use in young adults who have never smoked combustible tobacco was associated with lower vascular function and cardiorespiratory fitness.

    Tentative
    Evidence Score
    3.2±0.2
    Reliability
    Caveats
  3. Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer's disease

    2026 · Neurology and psychiatry

    Evidence Score
    3.4±0.2
    Reliability
    No concerns

How the rubric works →